Published date: 27 July 2018

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 14 June 2018

Contract summary

Industry

  • General anti-infectives for systemic use and vaccines - 33651000

Location of contract

Any region, Scotland, Northern Ireland

Value of contract

£0

Procurement reference

tender_171370/686622

Published date

27 July 2018

Closing date

14 June 2018

Contract start date

15 June 2018

Contract end date

6 July 2018

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of botulism antitoxin heptavalent ((A,B,C,D,E,F,G) - (Equine)) for use as part of the stockpile of emergency medicines in response to incidents and within business as usual within the NHS.

More information

Attachments

Award information

Awarded date

15 June 2018

Contract start date

15 June 2018

Contract end date

6 July 2018

Total value of contract

£0

This contract was awarded to 1 supplier.

Emergent BioSolutions Inc.

Address

Winnipeg, Canada

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

lynne.nichols@dh.gsi.gov.uk